Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
About this item
Full title
Author / Creator
Ward, Brian J. , Gobeil, Philipe , Séguin, Annie , Atkins, Judith , Boulay, Iohann , Charbonneau, Pierre-Yves , Couture, Manon , D’Aoust, Marc-André , Dhaliwall, Jiwanjeet , Finkle, Carolyn , Hager, Karen , Mahmood, Asif , Makarkov, Alexander , Cheng, Matthew P. , Pillet, Stéphane , Schimke, Patricia , St-Martin, Sylvie , Trépanier, Sonia and Landry, Nathalie
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being deployed, but the global need greatly exceeds the supply, and different formulations might be required for specific populations. Here we report Day 42 interim safety and immunogenicity data from an observer-blinded, dose escalation, randomized controlled study o...
Alternative Titles
Full title
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Authors, Artists and Contributors
Author / Creator
Gobeil, Philipe
Séguin, Annie
Atkins, Judith
Boulay, Iohann
Charbonneau, Pierre-Yves
Couture, Manon
D’Aoust, Marc-André
Dhaliwall, Jiwanjeet
Finkle, Carolyn
Hager, Karen
Mahmood, Asif
Makarkov, Alexander
Cheng, Matthew P.
Pillet, Stéphane
Schimke, Patricia
St-Martin, Sylvie
Trépanier, Sonia
Landry, Nathalie
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8205852
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8205852
Other Identifiers
ISSN
1078-8956
E-ISSN
1546-170X
DOI
10.1038/s41591-021-01370-1
